VIRP Virbac SA

EPA · FR · Healthcare · Drug Manufacturers - General · corporate.virbac.com

307.00EUR-0.32%Mkt Cap: 2.80B $P/E: 16.52Today

Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Paci…

Industry Peers

Drug Manufacturers - General

Screen all

LLY

Eli Lilly and Company Common Stock

$1.02TUSDP/E 38.4

JNJ

Johnson & Johnson Common Stock

$617.01BUSDP/E 29.7

ABBV

AbbVie Inc. Common Stock

$464.43BUSDP/E 74.2

MRK

Merck & Company, Inc. Common Stock (new)

Novartis AG Common Stock

AstraZeneca PLC Ordinary Shares

Amgen Inc. - Common Stock

Gilead Sciences, Inc. - Common Stock

$179.47BUSD

NVO

Novo Nordisk A/S Common Stock

$164.79BUSDP/E 9.4

PFE

Pfizer, Inc. Common Stock

$158.45BUSDP/E 36.6

BMY

Bristol-Myers Squibb Company Common Stock

$124.91BUSDP/E 13.5

SNY

Sanofi - American Depositary Shares

$95.65BUSDP/E 21.8

GSK

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Key Statistics

Company

Market Cap2.80B USD

Enterprise Value3.01B USD

Revenue (TTM)1.62B USD

Gross Profit1.06B USD

Net Income (TTM)164.01M USD

Revenue/Share178.36 EUR

Last Price307.00 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees6.4K

CountryFR

SectorHealthcare

IndustryDrug Manufacturers - General

ISINFR0000031577

Valuation

P/E (Trailing)16.52

P/E (Forward)13.38

PEG3.27

EV/EBITDA9.49

EV/Revenue1.85

P/S1.73

P/B2.29

EPS (TTM)18.58

EPS (Forward)23.02

52W Range

297.0011% of range389.50

52W High389.50 EUR

52W Low297.00 EUR

Profitability

Gross Margin66.58%

Oper. Margin18.09%

EBITDA Margin19.53%

Profit Margin10.30%

ROE13.41%

ROA7.88%

Growth

Revenue Growth4.00%

Earnings Growth5.90%

Cash Flow & Leverage

Operating CF216.29M USD

CapEx (TTM)111.02M USD

FCF Margin9.30%

FCF Yield5.40%

Net Debt205.36M USD

Net Debt/EBITDA0.65

Balance Sheet

Debt/Equity0.26

Current Ratio1.77

Quick Ratio0.93

Book Value/Sh134.31 EUR

Cash/Share20.58 EUR

Dividends

Fwd Div Rate1.45 EUR

Trail. Div Rate1.45 EUR

Div. Yield0.47%

5Y Avg Yield0.36%

Payout Ratio7.80%

Ex-Div DateJul 2, 2026

Pay Date—

Splits

Last Split4:1

Split DateJul 30, 2002

Analyst Consensus

Rating1.4 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)412.75 EUR

Upside (mean)+34.4%

Target Range360.00 EUR – 440.00 EUR

360.00+34.4% to mean440.00

# Analysts8

Ownership

Shares Out.8.38M

Float4.13M

Insiders50.82%

Institutions25.82%

Technical

SMA 50323.31 (-5.0%)

SMA 200344.69 (-10.9%)

Beta0.77

S&P 52W Chg14.58%

Avg Vol (30d)6.39K

Avg Vol (10d)7.31K

Technical Indicators

RSI (14)43.0

MACD-4.2278

MACD Signal-5.0250

MACD Hist.+0.7971

BB Upper318.03 EUR

BB Middle309.35 EUR

BB Lower300.67 EUR

BB Width5.61%

ATR (14)7.317 EUR

Vol Ratio (20d)0.73x